Lisa Rojkjaer serves as Executive at Viracta Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Lisa Rojkjaer has executed 15 insider transactions totaling $50.8K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 27, 2023 involved selling 2,156 shares valued at $3.6K.
Lisa Rojkjaer currently holds 48,087 shares of Viracta Therapeutics, Inc. (VIRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lisa Rojkjaer has been a net seller of VIRX stock. They have purchased $0 and sold $50.8K worth of shares.
Lisa Rojkjaer's most recent insider trade was on Feb 27, 2023, when they sold 2,156 shares at $1.68 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 28, 2022 | VIRX | $5.8K | Sale | 2,116 | $2.72 | Discretionary |
| Nov 25, 2022 | VIRX | $0 | Option Exercise | 4,127 | $N/A | Discretionary |
| Aug 26, 2022 | VIRX | $8.8K | Sale | 2,190 | $4.01 | Discretionary |
| Aug 25, 2022 | VIRX | $0 | Option Exercise | 4,127 | $N/A | Discretionary |
| May 26, 2022 | VIRX | $4.1K | Sale | 2,154 | $1.90 | Discretionary |
| May 25, 2022 | VIRX | $0 | Option Exercise | 4,127 | $N/A | Discretionary |
| Feb 28, 2022 | VIRX | $6.7K | Sale | 2,395 | $2.78 | Discretionary |
| Feb 25, 2022 | VIRX | $0 | Option Exercise | 4,127 | $N/A | Discretionary |
| Nov 29, 2021 | VIRX | $12.5K | Sale | 2,591 | $4.82 | Discretionary |
| Nov 26, 2021 | VIRX | $9.4K | Sale | 1,950 | $4.80 | Discretionary |
| Nov 25, 2021 | VIRX | $0 | Option Exercise | 8,254 | $N/A | Discretionary |
| May 11, 2021 | VIRX | $41.2K | Option Exercise | 32,689 | $1.26 | Discretionary |
| May 11, 2021 | VIRX | $7.4K | Option Exercise | 2,061 | $3.58 | Discretionary |